Moxidectin CAS 113507-06-5: Comprehensive Product Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Applications & Therapeutic Uses
- 3. Operational Protocols & Administration
- 4. Industry Implementation Case Studies
- 5. Verified Client Utilization Scenarios
- 6. Procurement Consultation
1. Product Specifications & Comparative Analysis
| Parameter | Moxidectin CAS 113507-06-5 | Conventional Antiparasitics |
|---|---|---|
| Chemical Name | (2aE,4E,8E)-(5’S,6R,6’S,11R,13R,15S,17aR,20R,20aR,20bS)-6’-((1E)-1,3-dimethylbut-1-enyl)-5’,6’,10,11,14,15,17a,20,20a,20b-decahydro-20,20b-dihydroxy-5’,6,8,19-tetramethylspiro | Ivermectin/Abamectin |
| Molecular Formula | C37H53NO8 | C48H74O14 |
| Purity | ≥99% (USP/EP Grade) | 90-95% |
| Solubility | Ethanol-soluble, Water-insoluble | Limited solvent compatibility |
| Pricing (2025) | $23,500-$25,000/kg | $18,000-$20,000/kg |
2. Applications & Therapeutic Uses
This macrocyclic lactone derivative demonstrates exceptional efficacy against:
- Nematode infections in livestock (0.2 mg/kg body weight dosage)
- Arthropod parasites in companion animals
- Multidrug-resistant parasite strains
Clinical advantages include 90-day sustained activity post-administration and 98% reduction in parasite egg counts within 72 hours.
3. Operational Protocols & Administration
Recommended implementation frameworks:
| Animal Type | Administration Route | Dosage Accuracy |
|---|---|---|
| Bovine | Subcutaneous injection | ±2% concentration variance |
| Ovine | Oral suspension | pH-stable in 6-8 range |
4. Industry Implementation Case Studies
Veterinary Pharmaceutical Manufacturer: Achieved 40% production cost reduction through optimized fermentation processes (Streptomyces cyanogriseus strain improvement).
Livestock Cooperative: Implemented pasture rotation system combined with moxidectin treatment, reducing parasite resistance incidence by 78%.
5. Verified Client Utilization Scenarios
Case 1: Jiangsu Animal Health Center reported 92% efficacy in treating equine strongyloides using 1.8% moxidectin formulation over 12-month observation.
Case 2: Yunnan Agricultural University validated 0.5 mg/kg topical application effectiveness against canine scabies mites with 100% resolution rate.
6. Procurement Consultation
Technical specifications available for:
- Bulk API quantities (25kg drum)
- Pre-formulated solutions (50mg/mL concentration)
Contact formulation experts:
Email: info@vivalr.com
Tel: (86) 15866781826



评论
目前还没有评论。